The Bing Center for Waldenström's Macroglobulinemia (WM) is the largest center in the world that is dedicated to the study and development of new, targeted treatments for WM and related Immunoglobulin M (IgM) disorders including IgM related neuropathy, and Bing Neel Syndrome. The Center is credited with the discovery of the MYD88 and CXCR4 mutations in WM, the approval of the first ever drug for WM (ibrutinib), and advancement of numerous new drugs for WM through clinical trials.

Our experts concentrate exclusively on patients with Waldenström’s macroglobulinemia (WM) and related immunoglobulin M (IgM) disorders. We provide expert care in the treatment of complications of WM including IgM neuropathy, amyloidosis, central nervous system involvement by WM (Bing Neel Syndrome), transformation to aggressive lymphoma, cryoglobulinemia and cold agglutinin disease. We offer an extensive array of treatment options and development of a personalized, genomic based treatment plan, offering the latest therapies (chemo-immunotherapy, antibody and cellular immunotherapies, targeted agents including BTK and BCL2 inhibitors).

The Center is part of the Center for Hematologic Oncology, which includes the hematopoietic stem cell transplantation program, and the cellular therapies center — among the largest and most experienced in the world.

Exceptional Care for Patients with Waldenström's Macroglobulinemia

•   The largest referral center for Waldenström's macroglobulinemia in the world.
•   A highly specialized center focusing exclusively on Waldenström's diagnostics, treatment planning, therapy, and research.
•   Genomic-based treatment options.
•   Carefully considered approach that does not always include immediate treatment.
•   Care plans tailored to the needs of each patient, from the first meeting through subsequent treatments in the years to come.
•   Consultations and second opinions for patients and physicians around the world.
•   Pioneering research in genomic sequencing and related treatments that is setting the standard of care for this disease around the world.
•   Physician-scientists who are not only part of the care team, but who also work in our labs to develop drugs that target the genetic drivers of Waldenström's, bringing new and more effective treatments to patients quickly.
•   Our specialists establish guidelines for workup, diagnosis, prognosis, response, and treatment. Our experts are part of every international committee on Waldenström's.
•   A treatment plan developed by a multidisciplinary team that works closely together to ensure that every approach is considered.

We Treat You, Not Just Your Cancer

Our entire team is here to support you throughout treatment and during recovery. You and your family have access to our full range of support services.
•   Nutrition services
•   Access to psychiatrists, psychologists, and social workers
•   Integrative therapies
•   Support specialists, programs, and services